论文部分内容阅读
目的:探讨匹多莫德联合童康片治疗小儿呼吸道感染的临床疗效。方法:搜集我院门诊就诊的小儿呼吸道感染确诊患者60例,随机分为试验组与对照组,各30例。试验组患儿给予匹多莫德联合童康片进行治疗,对照组仅给予匹多莫德治疗。随访观察并比较两组患儿用药后起效时间和临床疗效。结果:试验组较对照组治愈率更高、复发次数更少,经检验差异具有统计学意义(P<0.05)。结论:匹多莫德联合童康片治疗小儿呼吸道感染的治疗效果优于单纯使用匹多莫德,具有较高的应用价值。
Objective: To investigate the clinical efficacy of pidotimod combined with Tong Kang Tablets in children with respiratory tract infection. Methods: 60 cases of pediatric respiratory infection diagnosed in our outpatient clinic were collected and randomly divided into experimental group and control group, with 30 cases in each group. The children in the experimental group were treated with Pidotimod in combination with Tongkang Tablet, and the control group only with Pidotimod. Follow-up observation and comparison of two groups of children with medication onset time and clinical efficacy. Results: The cure rate of the experimental group was higher than that of the control group, with fewer recurrences. The difference was statistically significant (P <0.05). CONCLUSION: Pidotimod and Tong Kang Tablets are superior to Pidotimod in the treatment of respiratory tract infections in children, which is of high value.